Bausch Health considers selling Bausch + Lomb to complete their corporate separation.

Bausch Health, a global pharmaceutical company, is exploring the potential sale of its subsidiary, Bausch + Lomb, as part of efforts to complete their separation. The company’s board has authorized management to consider this option, but no decision has been made, and a sale is not guaranteed. This move comes in response to recent market rumors, and Bausch Health will share more details as needed.

3 months ago
24 Articles